NCT00310271View on ClinicalTrials.gov

A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

December 31, 2006

Conditions
HSV-2
Interventions
BIOLOGICAL

pPJV7630 with pPJV2012 administered by PMED

Trial Locations (1)

66219

CPC Phase I Unit, Lenexa

Sponsors

Lead Sponsor

PowderMed
All Listed Sponsors
lead

PowderMed

INDUSTRY